AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 165 filers reported holding AMNEAL PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $0 | -100.0% | 81 | -79.1% | 0.00% | – |
Q3 2019 | $1,000 | -100.0% | 387 | -100.0% | 0.00% | -100.0% |
Q1 2019 | $25,581,000 | +4.0% | 1,805,274 | -0.7% | 0.41% | -15.1% |
Q4 2018 | $24,606,000 | -45.9% | 1,818,637 | -11.3% | 0.48% | -33.7% |
Q3 2018 | $45,484,000 | +41.6% | 2,049,765 | +4.7% | 0.73% | +39.2% |
Q2 2018 | $32,113,000 | – | 1,956,906 | – | 0.53% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fosun International Ltd | 21,521,301 | $83,503,000 | 7.34% |
Eversept Partners, LP | 2,656,208 | $10,306,087 | 2.29% |
TPG Group Holdings (SBS) Advisors, Inc. | 16,213,367 | $62,908,000 | 1.13% |
Prosight Management, LP | 512,659 | $1,989,000 | 0.95% |
THB ASSET MANAGEMENT | 833,104 | $3,232,000 | 0.90% |
GLOBEFLEX CAPITAL L P | 251,696 | $977,000 | 0.26% |
XTX MARKETS LLC | 10,243 | $40,000 | 0.19% |
HUSSMAN STRATEGIC ADVISORS, INC. | 102,000 | $396,000 | 0.10% |
PA Capital LLC | 33,874 | $132,000 | 0.09% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 60,900 | $236,000 | 0.07% |